Security file · CUSIP 36269B105
GANX
GAIN THERAPEUTICS INC · US listing · held by 1 tracked manager in Q2 2026.
Tracked holders · Q2 2026
1
+0 vs Q1 2026
Aggregate reported value
$1.15M
sum of holders' reported positions
New holders this quarter
0
0 added · 0 trimmed
Holder return since filing
-54.2%
weighted by each holder's position share · since filing
Ownership · Q2 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | David Einhorn - Greenlight Capitalfiled 14 Aug ET | 0.03% | 566K | +0.0% | $2 | -54.2% | $1.15M | Held |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q2 2026 | 1 | +0 | $1.15M | 566K |
| Q1 2026 | 1 | +0 | $1.10M | 566K |
| Q4 2025 | 1 | +0 | $1.82M | 566K |
| Q3 2025 | 1 | +0 | $1.00M | 566K |
| Q2 2025 | 1 | +0 | $1.02M | 566K |
| Q1 2025 | 1 | +0 | $1.08M | 566K |
| Q4 2024 | 1 | +0 | $1.22M | 566K |
| Q3 2024 | 1 | +0 | $1.01M | 566K |
| Q2 2024 | 1 | +0 | $725K | 566K |
| Q1 2024 | 1 | — | $2.13M | 566K |